View Older Stories
-
RBC Capital Assumes Thermo Fisher Scientific (TMO) at Sector Perform
-
Thermo Fisher Scientific (TMO) PT Lowered to $600 at Stifel
-
Thermo Fisher Scientific (TMO) PT Lowered to $630 at BofA Securities
-
Thermo Fisher slips in premarket despite beating Q1 forecasts
-
Thermo Fisher Scientific (TMO) Tops Q1 EPS by 19c, Beats on Revenue
-
Thermo Fisher Scientific (TMO) PT Lowered to $625 at TD Cowen
-
Thermo Fisher partners with Singapore biobank for proteomics study
-
Citi Adjusts Catalyst Watch List
-
These are the 10 best stocks to own in Q2: BofA
-
Evercore: ' Latest Survey Work Positions 2026 As Better Year For Biopharma Spending'
-
Thermo Fisher Scientific (TMO) Raises Quarterly Dividend 9.3% to $0.47; 0.4% Yield
-
Accountability Research Upgrades Thermo Fisher Scientific (TMO) to Buy
-
Stifel: Thermo Fisher Scientific (TMO) a Preferred Name to Re-Engage with Tools in 2026
-
Thermo Fisher Scientific (TMO) PT Lowered to $683 at TD Cowen
-
Thermo Fisher Sees 2026 Revenue Of $46.3B To $47.2B
-
Thermo Fisher beats fourth-quarter expectations, shares climb
-
Thermo Fisher Scientific (TMO) Tops Q4 EPS by 12c
-
Thermo Fisher Scientific announces executive departures and leadership changes
-
HSBC lists 11 potential U.S. outperformers heading into earnings
-
Thermo Fisher Scientific (TMO) PT Raised to $700 at Stifel
-
Thermo Fisher Scientific (TMO) puts more active than calls into the annual J.P. Morgan Healthcare Conference
-
Citi Adjusts Large Cap Recommended List, Micron (MU) Removed
-
Goldman Sachs starts Life Sciences Tools coverage, rates these 3 stocks at Buy
-
Goldman Sachs Starts Thermo Fisher Scientific (TMO) at Buy
-
KeyBanc on Life Sciences Tools & Services: 'We Highlight Our Favored 2026 "Tools" Stocks'
-
KeyBanc Upgrades Thermo Fisher Scientific (TMO) to Overweight
-
Thermo Fisher Scientific expands bioprocess centers across Asia
-
Morgan Stanley Assumes Thermo Fisher Scientific (TMO) at Overweight
-
Thermo Fisher gets FDA clearance for multiple myeloma diagnostic system
-
Thermo Fisher authorizes $5 billion share repurchase program
-
Thermo Fisher Scientific (TMO) Declares $0.43 Quarterly Dividend; 0.3% Yield
-
Thermo Fisher Scientific (TMO) Nears Takeover Of Clario At About $10 bln Value- FT
-
Thermo Fisher Scientific (TMO) PT Raised to $654 at TD Cowen
-
Thermo Fisher Scientific (TMO) PT Raised to $610 at Evercore ISI
-
Thermo Fisher Scientific (TMO) Tops Q3 EPS by 29c
-
Thermo Fisher Scientific earnings preview Q3: stronger print expected amid life sciences recovery
-
Thermo Fisher Scientific partners with OpenAI to speed drug development
-
KeyBanc Reiterates Sector Weight Rating on Thermo Fisher Scientific (TMO)
-
Thermo Fisher Scientific (TMO) call put ratio 10.1 calls to 1 put with a focus on November calls
-
Bernstein on Thermo Fisher Scientific (TMO): 'Is Now the Time To Invest?... Buy the Strength'
-
Bernstein Reiterates Outperform Rating on Thermo Fisher Scientific (TMO)
-
Barclays Upgrades Thermo Fisher Scientific (TMO) to Overweight
-
William Blair Starts Thermo Fisher Scientific (TMO) at Outperform
-
Bernstein on Thermo Fisher Scientific (TMO): 'Buy the Strength'; PT Raised
-
HSBC Downgrades Thermo Fisher Scientific (TMO) to Hold
-
Thermo Fisher Scientific (TMO) PT Lowered to $583 at Stifel
-
Thermo Fisher Scientific (TMO) call put ratio 3.4 calls to 1 put with a focus on October calls as share price up 10%
-
Thermo Fisher Scientific (TMO) Tops Q2 EPS by 13c, Beats on Revenue
-
Thermo Fisher Scientific (TMO) PT Lowered to $550 at TD Cowen
-
Thermo Fisher to acquire Sanofi's New Jersey manufacturing site

